Alexandria Real Estate Equities, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Peter Moglia
- Full Time Employees
- 514
- Sector
- Real Estate
- Industry
- REIT - Office
- Address
- 26 North Euclid Avenue Pasadena CA United States of America 91101-6104
- IPO Date
- May 28, 1997
- CIK
- 0001035443
- Website
- are.com
- Similar Companies
- Business
- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company founded in 1994 and headquartered in Pasadena, California, is a leading urban life science real estate investment trust that owns, operates, develops, and redevelops Class A/A+ collaborative Megacampus ecosystems for lease to life science, agtech, technology, and digital health tenants. The company focuses on AAA innovation cluster locations across North America, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City, serving multinational pharmaceutical firms, biotechnology companies, medical research institutions, government agencies, non-profits, and venture capital entities through its 39.7 million rentable square feet of operating properties and 4.4 million square feet under construction as of June 30, 2025. Alexandria also deploys strategic venture capital via its Alexandria Venture Investments platform, which has backed disruptive life science innovators since 1996 to foster industry insights and tenant relationships. In recent developments, Alexandria has advanced its 2025 capital recycling strategy by executing over $1.1 billion in asset sales through the third quarter, including full dispositions of non-core assets like Pacific Technology Park, land parcels representing 20-30% of total sales, and partial interest transactions to fund higher-yield development projects; the company anticipates further $1.1 billion in sales over the next two quarters while shifting toward build-to-suit Megacampus initiatives amid moderated biotech demand. Progress on key projects includes leasing momentum at developments such as 311 Arsenal, 1450 Owens, 269 East Grand, 701 Dexter, and 99 Coolidge with average lease terms of 12.3 years, alongside strategic partnerships like its collaboration with Eli Lilly anchoring One Alexandria Square in Torrey Pines. Additionally, Alexandria Venture Investments received the 2025 Charles A. Sanders, MD, Partnership Award for its ecosystem contributions.
Company News
Alexandria Real Estate Equities (ARE) Up 5.7% Since Last Earnings Report: Can It Continue?
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 3Q26
Algert Global LLC Purchases 40,320 Shares of Alexandria Real Estate Equities, Inc. $ARE
ADAR1 Capital Management LLC Invests $1.03 Million in Alexandria Real Estate Equities, Inc. $ARE
Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2026 Operating and Financial Results Conference Call and Webcast on October 27, 2026
Handelsbanken Fonder AB Acquires 25,300 Shares of Alexandria Real Estate Equities, Inc. $ARE
Alexandria Real Estate Equities, Inc. $ARE Position Lifted by Bank of America Corp DE
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057
Alexandria Real Estate: A 50% Margin Of Safety And A Secure 5.9% Yield
Alexandria Real Estate Equities, Inc. (ARE) Q2 2026 Earnings Call Transcript
Alexandria Real Estate Equities Q2 Earnings Call Highlights
ARE's Q2 FFO Beats Estimates on Leasing Momentum, Rental Rates Improve
Alexandria Real Estate: Market Missing A Recovery Coming Sooner Than Expected
Alexandria Real Estate Equities (ARE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Alexandria Real Estate Equities (ARE) Q2 FFO and Revenues Top Estimates
Alexandria Real Estate Equities, Inc. Reports 2Q26 and 1H26 Net (Loss) Income per Share - Diluted of $(0.43) and $1.68, respectively, and 2Q26 and 1H26 FFO per Share - Diluted, as Adjusted, of $1.73 and $3.46, respectively
Is the Options Market Predicting a Spike in Alexandria Stock?
Alexandria Real Estate Equities, Inc. Announces Foundational Milestone in Mission-Critical Partnership with the Foundation for the National Institutes of Health to Advance Precision Medicine for Depression
Alexandria Real Estate Equities, Inc. $ARE Shares Acquired by Dimensional Fund Advisors LP
Arrowstreet Capital Limited Partnership Makes New Investment in Alexandria Real Estate Equities, Inc. $ARE